toltrazuril / iron (III) ion
Baycox Iron is a veterinary medicine. It is used in young piglets on farms which have been affected in the past by the parasitic infection coccidiosis to prevent diarrhoea caused by a new coccidiosis infection. Coccidiosis is a disease of the gut which results in reduced growth due to diarrhoea. Infected piglets shed disease spores (oocysts) in their faeces that can spread the infection. Baycox Iron is also used to reduce spread of the infection through passage of oocysts in faeces, and at the same time to prevent iron deficiency anaemia due to the limited iron reserves of new-born piglets, low iron content of milk and high growth rate of suckling piglets.
Baycox Iron contains the active substances toltrazuril and gleptoferron (an iron-containing compound).
Baycox Iron : EPAR - Medicine overview (PDF/75.85 KB)
First published: 12/06/2019
|Agency product number||
|International non-proprietary name (INN) or common name||
|Anatomical therapeutic chemical veterinary (ATCvet) codes||
Bayer Animal Health GmbH
|Date of issue of marketing authorisation valid throughout the European Union||
31/03/2020 Baycox Iron - EMEA/V/C/004794 - IG/1213
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
For the concurrent prevention of clinical signs of coccidiosis (such as diarrhoea) in neonatal piglets on farms with a confirmed history of coccidiosis caused by Cystoisospora suis, and prevention of iron deficiency anaemia.
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 5-7 October 202108/10/2021
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 15-17 June 202118/06/2021
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 April 202116/04/2021
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 6-7 October 202009/10/2020